{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["daidzein", "nanotechnology", "pharmacological applications", "polymer-lipid nanoparticles", "polymeric nanoparticles", "solid lipid nanoparticles"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36838751", "DateCompleted": {"Year": "2023", "Month": "02", "Day": "28"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "13"}], "Language": ["eng"], "ELocationID": ["1765", "10.3390/molecules28041765"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "28", "Issue": "4", "PubDate": {"Year": "2023", "Month": "Feb", "Day": "13"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Unveiling the Pharmacological and Nanotechnological Facets of Daidzein: Present State-of-the-Art and Future Perspectives.", "Abstract": {"AbstractText": ["Herbal drugs have been attracting much scientific interest in the last few decades and nowadays, phytoconstituents-based research is in progress to disclose their unidentified medicinal potential. Daidzein (DAI) is the natural phytoestrogen isoflavone derived primarily from leguminous plants, such as the soybean and mung bean, and its IUPAC name is 4',7-dihydroxyisoflavone. This compound has received great attention as a fascinating pharmacophore with remarkable potential for the therapeutic management of several diseases. Certain pharmacokinetic properties of DAI such as less aqueous solubility, low permeability, and poor bioavailability are major obstacles restricting the therapeutic applications. In this review, distinctive physicochemical characteristics and pharmacokinetics of DAI has been elucidated. The pharmacological applications in treatment of several disorders like oxidative stress, cancer, obesity, cardiovascular, neuroprotective, diabetes, ovariectomy, anxiety, and inflammation with their mechanism of action are explained. Furthermore, this review article comprehensively focuses to provide up-to-date information about nanotechnology-based formulations which have been investigated for DAI in preceding years which includes polymeric nanoparticles, solid lipid nanoparticles, nanostructured lipid carrier, polymer-lipid nanoparticles, nanocomplexes, polymeric micelles, nanoemulsion, nanosuspension, liposomes, and self-microemulsifying drug delivery systems."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to Be University), Ambala 133207, India."}], "LastName": "Singh", "ForeName": "Sukhbir", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to Be University), Ambala 133207, India."}], "LastName": "Grewal", "ForeName": "Sonam", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to Be University), Ambala 133207, India."}], "LastName": "Sharma", "ForeName": "Neelam", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Health Sciences & Technology, University of Petroleum and Energy Studies, Bidholi, Dehradun 248007, India."}], "LastName": "Behl", "ForeName": "Tapan", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to Be University), Ambala 133207, India."}], "LastName": "Gupta", "ForeName": "Sumeet", "Initials": "S"}, {"Identifier": ["0000-0002-5227-3954"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj 11942, Saudi Arabia."}], "LastName": "Anwer", "ForeName": "Md Khalid", "Initials": "MK"}, {"Identifier": ["0000-0001-9187-5504"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Bromatology and Toxicology, Faculty of Pharmacy and Biochemistry, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru."}, {"Identifier": [], "Affiliation": "E-Health Research Center, Universidad de Ciencias y Humanidades, Lima 15081, Peru."}], "LastName": "Vargas-De-La-Cruz", "ForeName": "Celia", "Initials": "C"}, {"Identifier": ["0000-0003-2077-1278"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Health Sciences & Technology, University of Petroleum and Energy Studies, Bidholi, Dehradun 248007, India."}, {"Identifier": [], "Affiliation": "Substance Abuse and Toxicology Research Centre, Jazan University, Jazan 45142, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Science, Saveetha University, Chennai 602117, India."}], "LastName": "Mohan", "ForeName": "Syam", "Initials": "S"}, {"Identifier": ["0000-0003-3236-1292"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania."}, {"Identifier": [], "Affiliation": "Doctoral School of Biomedical Sciences, University of Oradea, 410087 Oradea, Romania."}], "LastName": "Bungau", "ForeName": "Simona Gabriela", "Initials": "SG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania."}], "LastName": "Bumbu", "ForeName": "Adrian", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "6287WC5J2L", "NameOfSubstance": "daidzein"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoflavones"}, {"RegistryNumber": "0", "NameOfSubstance": "Micelles"}, {"RegistryNumber": "0", "NameOfSubstance": "Polymers"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Drug Delivery Systems"}, {"QualifierName": [], "DescriptorName": "Nanotechnology"}, {"QualifierName": ["chemistry"], "DescriptorName": "Nanoparticles"}, {"QualifierName": [], "DescriptorName": "Isoflavones"}, {"QualifierName": [], "DescriptorName": "Micelles"}, {"QualifierName": ["chemistry"], "DescriptorName": "Polymers"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Karunamoorthi K., Jegajeevanram K., Vijayalakshmi J., Mengistie E. Traditional medicinal plants: A source of phytotherapeutic modality in resource-constrained health care settings. J. Evid. Based. Complement. Altern. Med. 2013;18:67\u201374. doi: 10.1177/2156587212460241.", "ArticleIdList": ["10.1177/2156587212460241"]}, {"Citation": "Verma S., Singh S.P. Current and future status of herbal medicines. Vet. World. 2008;1:347. doi: 10.5455/vetworld.2008.347-350.", "ArticleIdList": ["10.5455/vetworld.2008.347-350"]}, {"Citation": "Foghis M., Bungau S.G., Bungau A.F., Vesa C.M., Purza A.L., Tarce A.G., Tit D.M., Pallag A., Behl T., Hassan S.S.U., et al. Plants-based medicine implication in the evolution of chronic liver diseases. Biomed. Pharmacother. 2023;158:114207. doi: 10.1016/j.biopha.2022.114207.", "ArticleIdList": ["10.1016/j.biopha.2022.114207"]}, {"Citation": "Patle D., Vyas M., Khatik G.L. A review on natural products and herbs used in the management of diabetes. Curr. Diabetes Rev. 2021;17:186\u2013197.", "ArticleIdList": ["32268866"]}, {"Citation": "Gitea M.A., Bungau S.G., Gitea D., Pasca B.M., Purza A.L., Radu A.-F. Evaluation of the Phytochemistry\u2013Therapeutic Activity Relationship for Grape Seeds Oil. Life. 2023;13:178. doi: 10.3390/life13010178.", "ArticleIdList": ["10.3390/life13010178", "PMC9864701", "36676127"]}, {"Citation": "Vijayalakshmi R., Ravindhran R. Preliminary comparative phytochemical screening of root extracts of Diospyrus ferrea (Wild.) Bakh and Aerva lanata (L.) Juss. Ex Schultes. Asian J. Plant Sci. Res. 2011;2:581\u2013587."}, {"Citation": "Nandagoapalan V., Doss A., Marimuthu C. Phytochemical analysis of some traditional medicinal plants. Biosci. Discov. 2016;7:17\u201320."}, {"Citation": "Yadav M., Chatterji S., Gupta S.K., Watal G. Preliminary phytochemical screening of six medicinal plants used in traditional medicine. Int. J. Pharm. Pharm. Sci. 2014;6:539\u2013542."}, {"Citation": "Pal D., Verma P. Flavonoids: A powerful and abundant source of antioxidants. Int. J. Pharm. Pharm. Sci. 2013;5:95\u201398."}, {"Citation": "Panche A.N., Diwan A.D., Chandra S.R. Flavonoids: An overview. J. Nutr. Sci. 2016;5:e47. doi: 10.1017/jns.2016.41.", "ArticleIdList": ["10.1017/jns.2016.41", "PMC5465813", "28620474"]}, {"Citation": "Ku Y.-S., Ng M.-S., Cheng S.-S., Lo A.W.-Y., Xiao Z., Shin T.-S., Chung G., Lam H.-M. Understanding the composition, biosynthesis, accumulation and transport of flavonoids in crops for the promotion of crops as healthy sources of flavonoids for human consumption. Nutrients. 2020;12:1717. doi: 10.3390/nu12061717.", "ArticleIdList": ["10.3390/nu12061717", "PMC7352743", "32521660"]}, {"Citation": "G\u00f3rniak I., Bartoszewski R., Kr\u00f3liczewski J. Comprehensive review of antimicrobial activities of plant flavonoids. Phytochem. Rev. 2019;18:241\u2013272. doi: 10.1007/s11101-018-9591-z.", "ArticleIdList": ["10.1007/s11101-018-9591-z"]}, {"Citation": "Sivasankarapillai V.S., Nair R.M.K., Rahdar A., Bungau S., Zaha D.C., Aleya L., Tit D.M. Overview of the anticancer activity of withaferin A, an active constituent of the Indian ginseng Withania somnifera. Environ. Sci. Pollut. Res. Int. 2020;27:26025\u201326035. doi: 10.1007/s11356-020-09028-0.", "ArticleIdList": ["10.1007/s11356-020-09028-0", "32405942"]}, {"Citation": "Khuntia A., Martorell M., Ilango K., Bungau S.G., Radu A.-F., Behl T., Sharifi-Rad J. Theoretical evaluation of Cleome species\u2019 bioactive compounds and therapeutic potential: A literature review. Biomed. Pharmacother. 2022;151:113161. doi: 10.1016/j.biopha.2022.113161.", "ArticleIdList": ["10.1016/j.biopha.2022.113161", "35644118"]}, {"Citation": "Bellavia D., Dimarco E., Costa V., Carina V., De Luca A., Raimondi L., Fini M., Gentile C., Caradonna F., Giavaresi G. Flavonoids in bone erosive diseases: Perspectives in osteoporosis treatment. Trends Endocrinol. Metab. 2021;32:76\u201394. doi: 10.1016/j.tem.2020.11.007.", "ArticleIdList": ["10.1016/j.tem.2020.11.007", "33288387"]}, {"Citation": "Caro-Ordieres T., Mar\u00edn-Royo G., Opazo-R\u00edos L., Jim\u00e9nez-Castilla L., Moreno J.A., G\u00f3mez-Guerrero C., Egido J. The coming age of flavonoids in the treatment of diabetic complications. J. Clin. Med. 2020;9:346. doi: 10.3390/jcm9020346.", "ArticleIdList": ["10.3390/jcm9020346", "PMC7074336", "32012726"]}, {"Citation": "Bungau S., Vesa C.M., Abid A., Behl T., Tit D.M., Purza A.L., Pasca B., Todan L.M., Endres L. Withaferin A\u2014A Promising Phytochemical Compound with Multiple Results in Dermatological Diseases. Molecules. 2021;26:2407. doi: 10.3390/molecules26092407.", "ArticleIdList": ["10.3390/molecules26092407", "PMC8122412", "33919088"]}, {"Citation": "Behl T., Bungau S., Kumar K., Zengin G., Khan F., Kumar A., Kaur R., Venkatachalam T., Tit D.M., Vesa C.M., et al. Pleotropic Effects of Polyphenols in Cardiovascular System. Biomed. Pharmacother. 2020;130:110714. doi: 10.1016/j.biopha.2020.110714.", "ArticleIdList": ["10.1016/j.biopha.2020.110714", "34321158"]}, {"Citation": "Domaszewska-Szostek A., Puzianowska-Ku\u017anicka M., Kury\u0142owicz A. Flavonoids in skin senescence prevention and treatment. Int. J. Mol. Sci. 2021;22:6814. doi: 10.3390/ijms22136814.", "ArticleIdList": ["10.3390/ijms22136814", "PMC8267725", "34201952"]}, {"Citation": "Atkinson C., Frankenfeld C.L., Lampe J.W. Gut bacterial metabolism of the soy isoflavone daidzein: Exploring the relevance to human health. Exp. Biol. Med. 2005;230:155\u2013170. doi: 10.1177/153537020523000302.", "ArticleIdList": ["10.1177/153537020523000302", "15734719"]}, {"Citation": "Sun M.-Y., Ye Y., Xiao L., Rahman K., Xia W., Zhang H. Daidzein: A review of pharmacological effects. Afr. J. Tradit. Complement. Altern. Med. 2016;13:117\u2013132. doi: 10.21010/ajtcam.v13i3.15.", "ArticleIdList": ["10.21010/ajtcam.v13i3.15"]}, {"Citation": "Alshehri M.M., Sharifi-Rad J., Herrera-Bravo J., Jara E.L., Salazar L.A., Kregiel D., Uprety Y., Akram M., Iqbal M., Martorell M. Therapeutic potential of isoflavones with an emphasis on daidzein. Oxid. Med. Cell. Longev. 2021;2021:6331630. doi: 10.1155/2021/6331630.", "ArticleIdList": ["10.1155/2021/6331630", "PMC8448605", "34539970"]}, {"Citation": "Nan G., Shi J., Huang Y., Sun J., Lv J., Yang G., Li Y. Dissociation constants and solubilities of daidzein and genistein in different solvents. J. Chem. Eng. Data. 2014;59:1304\u20131311. doi: 10.1021/je4010905.", "ArticleIdList": ["10.1021/je4010905"]}, {"Citation": "Huang Z.-R., Hung C.-F., Lin Y.-K., Fang J.-Y. In vitro and in vivo evaluation of topical delivery and potential dermal use of soy isoflavones genistein and daidzein. Int. J. Pharm. 2008;364:36\u201344. doi: 10.1016/j.ijpharm.2008.08.002.", "ArticleIdList": ["10.1016/j.ijpharm.2008.08.002", "18761396"]}, {"Citation": "Qiu F., Chen X., Song B., Zhong D., Liu C. Influence of dosage forms on pharmacokinetics of daidzein and its main metabolite daidzein-7-O-glucuronide in rats. Acta Pharmacol. Sin. 2005;26:1145\u20131152. doi: 10.1111/j.1745-7254.2005.00187.x.", "ArticleIdList": ["10.1111/j.1745-7254.2005.00187.x", "16115384"]}, {"Citation": "Ma Y., Zhao X., Li J., Shen Q. The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability. Int. J. Nanomed. 2012;7:559.", "ArticleIdList": ["PMC3277436", "22346351"]}, {"Citation": "Kaplan A.B.U., \u00d6zt\u00fcrk N., \u00c7etin M., Vural I., \u00d6zer T.\u00d6. The nanosuspension formulations of daidzein: Preparation and in vitro characterization. Turk. J. Pharm. Sci. 2022;19:84. doi: 10.4274/tjps.galenos.2021.81905.", "ArticleIdList": ["10.4274/tjps.galenos.2021.81905", "PMC8892555", "35227054"]}, {"Citation": "Bhalla Y., Chadha K., Chadha R., Karan M. Daidzein cocrystals: An opportunity to improve its biopharmaceutical parameters. Heliyon. 2019;5:e02669. doi: 10.1016/j.heliyon.2019.e02669.", "ArticleIdList": ["10.1016/j.heliyon.2019.e02669", "PMC6861730", "31763466"]}, {"Citation": "Zhang Z., Huang Y., Gao F., Bu H., Gu W., Li Y. Daidzein\u2013phospholipid complex loaded lipid nanocarriers improved oral absorption: In vitro characteristics and in vivo behavior in rats. Nanoscale. 2011;3:1780\u20131787. doi: 10.1039/c0nr00879f.", "ArticleIdList": ["10.1039/c0nr00879f", "21350765"]}, {"Citation": "Sirotkin A.V., Alwasel S.H., Harrath A.H. The influence of plant isoflavones daidzein and equol on female reproductive processes. Pharmaceuticals. 2021;14:373. doi: 10.3390/ph14040373.", "ArticleIdList": ["10.3390/ph14040373", "PMC8073550", "33920641"]}, {"Citation": "Kwiecie\u0144 A., Ruda-Kucerova J., Kami\u0144ski K., Babinska Z., Popio\u0142ek I., Szczubia\u0142ka K., Nowakowska M., Walczak M. Improved pharmacokinetics and tissue uptake of complexed daidzein in rats. Pharmaceutics. 2020;12:162. doi: 10.3390/pharmaceutics12020162.", "ArticleIdList": ["10.3390/pharmaceutics12020162", "PMC7076374", "32079113"]}, {"Citation": "Amawi H., Ashby C.R., Tiwari A.K. Cancer chemoprevention through dietary flavonoids: What\u2019s limiting? Chin. J. Cancer. 2017;36:50. doi: 10.1186/s40880-017-0217-4.", "ArticleIdList": ["10.1186/s40880-017-0217-4", "PMC5477375", "28629389"]}, {"Citation": "Rafii F. The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol. Metabolites. 2015;5:56\u201373. doi: 10.3390/metabo5010056.", "ArticleIdList": ["10.3390/metabo5010056", "PMC4381290", "25594250"]}, {"Citation": "Chang Y., Choue R. Plasma pharmacokinetics and urinary excretion of isoflavones after ingestion of soy products with different aglycone/glucoside ratios in South Korean women. Nutr. Res. Pract. 2013;7:393\u2013399. doi: 10.4162/nrp.2013.7.5.393.", "ArticleIdList": ["10.4162/nrp.2013.7.5.393", "PMC3796665", "24133619"]}, {"Citation": "Ahmed T., Javed S., Tariq A., Onofrio G., Daglia M., Nabavi S.F., Nabavi S.M. Daidzein and its effects on brain. Curr. Med. Chem. 2017;24:365\u2013375.", "ArticleIdList": ["27804870"]}, {"Citation": "Xiao B.-X., Feng L., Cao F.-R., Pan R.-L., Liao Y.-H., Liu X.-M., Chang Q. Pharmacokinetic profiles of the five isoflavonoids from Pueraria lobata roots in the CSF and plasma of rats. J. Ethnopharmacol. 2016;184:22\u201329. doi: 10.1016/j.jep.2016.02.027.", "ArticleIdList": ["10.1016/j.jep.2016.02.027", "26923541"]}, {"Citation": "Laddha A.P., Murugesan S., Kulkarni Y.A. In-vivo and in-silico toxicity studies of daidzein: An isoflavone from soy. Drug Chem. Toxicol. 2022;45:1408\u20131416. doi: 10.1080/01480545.2020.1833906.", "ArticleIdList": ["10.1080/01480545.2020.1833906", "33059469"]}, {"Citation": "Sarasquete C., \u00dabeda-Manzanaro M., Ortiz-Delgado J.B. Toxicity and non-harmful effects of the soya isoflavones, genistein and daidzein, in embryos of the zebrafish, Danio rerio. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2018;211:57\u201367. doi: 10.1016/j.cbpc.2018.05.012.", "ArticleIdList": ["10.1016/j.cbpc.2018.05.012", "29870789"]}, {"Citation": "Foti P., Erba D., Spadafranca A., Ciappellano S., Bresciani J., Testolin G. Daidzein is absorbed by passive transport in isolated small intestine of rats. Nutr. Res. 2006;26:284\u2013288. doi: 10.1016/j.nutres.2006.06.005.", "ArticleIdList": ["10.1016/j.nutres.2006.06.005"]}, {"Citation": "Setchell K.D.R., Zhao X., Shoaf S.E., Ragland K. The pharmacokinetics of S-(-) equol administered as SE5-OH tablets to healthy postmenopausal women. J. Nutr. 2009;139:2037\u20132043. doi: 10.3945/jn.109.110874.", "ArticleIdList": ["10.3945/jn.109.110874", "19776178"]}, {"Citation": "Setchell K.D.R., Clerici C. Equol: Pharmacokinetics and biological actions. J. Nutr. 2010;140:1363S\u20131368S. doi: 10.3945/jn.109.119784.", "ArticleIdList": ["10.3945/jn.109.119784", "PMC2884334", "20519411"]}, {"Citation": "Chu H., Li J., Liu T., Miao N., Zhang W. Anticancer effects of Daidzein against the human melanoma cell lines involves cell cycle arrest, autophagy and deactivation of PI3K/AKT signalling pathways. J. BUON Off. J. Balk. Union Oncol. 2021;26:290.", "ArticleIdList": ["33721475"]}, {"Citation": "Yu Z., Yang L., Deng S., Liang M. Daidzein ameliorates LPS-induced hepatocyte injury by inhibiting inflammation and oxidative stress. Eur. J. Pharmacol. 2020;885:173399. doi: 10.1016/j.ejphar.2020.173399.", "ArticleIdList": ["10.1016/j.ejphar.2020.173399", "32712091"]}, {"Citation": "Inoue Y., Yoshida M., Ezawa T., Tanikawa T., Arce F., See G.L., Tomita J., Suzuki M., Oguchi T. Inclusion Complexes of Daidzein with Cyclodextrin-Based Metal\u2013Organic Framework-1 Enhance Its Solubility and Antioxidant Capacity. AAPS PharmSciTech. 2022;23:2. doi: 10.1208/s12249-021-02151-2.", "ArticleIdList": ["10.1208/s12249-021-02151-2", "34796406"]}, {"Citation": "Laddha A.P., Kulkarni Y.A. Daidzein ameliorates diabetic retinopathy in experimental animals. Life Sci. 2021;265:118779. doi: 10.1016/j.lfs.2020.118779.", "ArticleIdList": ["10.1016/j.lfs.2020.118779", "33217441"]}, {"Citation": "Herwana E., Pusparini P., Graciela A. High dietary daidzein intake lowers cholesterol levels among post-menopausal women. Universa Med. 2020;39:47\u201354. doi: 10.18051/UnivMed.2020.v39.47-54.", "ArticleIdList": ["10.18051/UnivMed.2020.v39.47-54"]}, {"Citation": "Laddha A.P., Kulkarni Y.A. Daidzein mitigates myocardial injury in streptozotocin-induced diabetes in rats. Life Sci. 2021;284:119664. doi: 10.1016/j.lfs.2021.119664.", "ArticleIdList": ["10.1016/j.lfs.2021.119664", "34090859"]}, {"Citation": "Li Y., Li Z., Liu S., Su Y., Li Y. Cardiotonic Activity of Daidzein Against Doxorubicin-lnduced Congestive Cardiac Failure in Rats. Curr. Top. Nutraceutical Res. 2022;20:106\u2013113."}, {"Citation": "Rawat S., Pathak S., Gupta G., Singh S.K., Singh H., Mishra A., Gilhotra R. Recent updates on daidzein against oxidative stress and cancer. EXCLI J. 2019;18:950.", "ArticleIdList": ["PMC6868922", "31762721"]}, {"Citation": "Amaral C., Toloi M.R.T., Vasconcelos L.D., Fonseca M.J.V., Correia-da-Silva G., Teixeira N. The role of soybean extracts and isoflavones in hormone-dependent breast cancer: Aromatase activity and biological effects. Food Funct. 2017;8:3064\u20133074. doi: 10.1039/C7FO00205J.", "ArticleIdList": ["10.1039/C7FO00205J", "28644496"]}, {"Citation": "Meng H., Fu G., Shen J., Shen K., Xu Z., Wang Y., Jin B., Pan H. Ameliorative effect of daidzein on cisplatin-induced nephrotoxicity in mice via modulation of inflammation, oxidative stress, and cell death. Oxid. Med. Cell. Longev. 2017;2017:3140680. doi: 10.1155/2017/3140680.", "ArticleIdList": ["10.1155/2017/3140680", "PMC5558675", "28831294"]}, {"Citation": "Magee P.J., Allsopp P., Samaletdin A., Rowland I.R. Daidzein, R-(+) equol and S-(\u2212) equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2. Eur. J. Nutr. 2014;53:345\u2013350. doi: 10.1007/s00394-013-0520-z.", "ArticleIdList": ["10.1007/s00394-013-0520-z", "23568763"]}, {"Citation": "Qin Y., Shu F., Zeng Y., Meng X., Wang B., Diao L., Wang L., Wan J., Zhu J., Wang J. Daidzein supplementation decreases serum triglyceride and uric acid concentrations in hypercholesterolemic adults with the effect on triglycerides being greater in those with the GA compared with the GG genotype of ESR-\u03b2 Rsa I. J. Nutr. 2014;144:49\u201354. doi: 10.3945/jn.113.182725.", "ArticleIdList": ["10.3945/jn.113.182725", "24225450"]}, {"Citation": "Sun J., Sun W.J., Li Z.Y., Li L., Wang Y., Zhao Y., Wang C., Yu L.R., Li L.Z., Zhang Y.L. Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. Int. Immunopharmacol. 2016;40:32\u201340. doi: 10.1016/j.intimp.2016.08.014.", "ArticleIdList": ["10.1016/j.intimp.2016.08.014", "27576059"]}, {"Citation": "Pizzino G., Irrera N., Cucinotta M., Pallio G., Mannino F., Arcoraci V., Bitto A. Oxidative stress: Harms and benefits for human health. Oxidative Med. Cell. Longev. 2017;2017:8416763. doi: 10.1155/2017/8416763.", "ArticleIdList": ["10.1155/2017/8416763", "PMC5551541", "28819546"]}, {"Citation": "Ahmed Q.U., Ali A.H.M., Mukhtar S., Alsharif M.A., Parveen H., Sabere A.S.M., Nawi M.S.M., Khatib A., Siddiqui M.J., Umar A. Medicinal potential of isoflavonoids: Polyphenols that may cure diabetes. Molecules. 2020;25:5491. doi: 10.3390/molecules25235491.", "ArticleIdList": ["10.3390/molecules25235491", "PMC7727648", "33255206"]}, {"Citation": "Lee D.E., Lee K.W., Byun S., Jung S.K., Song N., Lim S.H., Heo Y.-S., Kim J.E., Kang N.J., Kim B.Y. 7,3\u2032,4\u2032-Trihydroxyisoflavone, a metabolite of the soy isoflavone daidzein, suppresses ultraviolet B-induced skin cancer by targeting Cot and MKK4. J. Biol. Chem. 2011;286:14246\u201314256. doi: 10.1074/jbc.M110.147348.", "ArticleIdList": ["10.1074/jbc.M110.147348", "PMC3077626", "21378167"]}, {"Citation": "Velentzis L.S., Woodside J.V., Cantwell M.M., Leathem A.J., Keshtgar M.R. Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know. Eur. J. Cancer. 2008;44:1799\u20131806. doi: 10.1016/j.ejca.2008.05.019.", "ArticleIdList": ["10.1016/j.ejca.2008.05.019", "18614351"]}, {"Citation": "Liu M.M., Huang Y., Wang J. Developing phytoestrogens for breast cancer prevention. Anti-Cancer Agents Med. Chem. (Former. Curr. Med. Chem. Agents) 2012;12:1306\u20131313. doi: 10.2174/187152012803833062.", "ArticleIdList": ["10.2174/187152012803833062", "22583409"]}, {"Citation": "Abotaleb M., Samuel S.M., Varghese E., Varghese S., Kubatka P., Liskova A., B\u00fcsselberg D. Flavonoids in cancer and apoptosis. Cancers. 2018;11:28. doi: 10.3390/cancers11010028.", "ArticleIdList": ["10.3390/cancers11010028", "PMC6357032", "30597838"]}, {"Citation": "Bao C., Namgung H., Lee J., Park H.-C., Ko J., Moon H., Ko H.W., Lee H.J. Daidzein suppresses tumor necrosis factor-\u03b1 induced migration and invasion by inhibiting hedgehog/Gli1 signaling in human breast cancer cells. J. Agric. Food Chem. 2014;62:3759\u20133767. doi: 10.1021/jf500231t.", "ArticleIdList": ["10.1021/jf500231t", "24724627"]}, {"Citation": "Singh R.P., Agarwal R. Natural flavonoids targeting deregulated cell cycle progression in cancer cells. Curr. Drug Targets. 2006;7:345\u2013354. doi: 10.2174/138945006776055004.", "ArticleIdList": ["10.2174/138945006776055004", "16515531"]}, {"Citation": "Choi E.J., Kim G.-H. Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells. Phytomedicine. 2008;15:683\u2013690. doi: 10.1016/j.phymed.2008.04.006.", "ArticleIdList": ["10.1016/j.phymed.2008.04.006", "18541420"]}, {"Citation": "Wang B., Xu H., Hu X., Ma W., Zhang J., Li Y., Yu M., Zhang Y., Li X., Ye X. Synergetic inhibition of daidzein and regular exercise on breast cancer in bearing-4T1 mice by regulating NK cells and apoptosis pathway. Life Sci. 2020;245:117387. doi: 10.1016/j.lfs.2020.117387.", "ArticleIdList": ["10.1016/j.lfs.2020.117387", "32007575"]}, {"Citation": "Rabiau N., Kossa\u00ef M., Braud M., Chalabi N., Satih S., Bignon Y.-J., Bernard-Gallon D.J. Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by polymerase chain reaction arrays in human prostate cancer cell lines. Cancer Epidemiol. 2010;34:200\u2013206. doi: 10.1016/j.canep.2009.12.018.", "ArticleIdList": ["10.1016/j.canep.2009.12.018", "20097631"]}, {"Citation": "Guo J.M., Xiao B.X., Liu D.H., Grant M., Zhang S., Lai Y.F., Guo Y.B., Liu Q. Biphasic effect of daidzein on cell growth of human colon cancer cells. Food Chem. Toxicol. 2004;42:1641\u20131646. doi: 10.1016/j.fct.2004.06.001.", "ArticleIdList": ["10.1016/j.fct.2004.06.001", "15304310"]}, {"Citation": "Gheorghe G., Toth P.P., Bungau S., Behl T., Ilie M., Stoian A.P., Bratu O.G., Bacalbasa N., Rus M., Diaconu C.C. Cardiovascular Risk and Statin Therapy Considerations in Women. Diagnostics. 2020;10:483. doi: 10.3390/diagnostics10070483.", "ArticleIdList": ["10.3390/diagnostics10070483", "PMC7400394", "32708558"]}, {"Citation": "Reckelhoff J.F. Sex steroids, cardiovascular disease, and hypertension: Unanswered questions and some speculations. Hypertension. 2005;45:170\u2013174. doi: 10.1161/01.HYP.0000151825.36598.36.", "ArticleIdList": ["10.1161/01.HYP.0000151825.36598.36", "15583070"]}, {"Citation": "Ross R.L., Serock M.R., Khalil R.A. Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease. Curr. Cardiol. Rev. 2008;4:309\u2013322. doi: 10.2174/157340308786349462.", "ArticleIdList": ["10.2174/157340308786349462", "PMC2801863", "20066139"]}, {"Citation": "Feng H., Guo W., Han J., Li X.-A. Role of caveolin-1 and caveolae signaling in endotoxemia and sepsis. Life Sci. 2013;93:1\u20136. doi: 10.1016/j.lfs.2013.05.016.", "ArticleIdList": ["10.1016/j.lfs.2013.05.016", "PMC3733535", "23727353"]}, {"Citation": "Maxfield F.R., van Meer G. Cholesterol, the central lipid of mammalian cells. Curr. Opin. Cell Biol. 2010;22:422\u2013429. doi: 10.1016/j.ceb.2010.05.004.", "ArticleIdList": ["10.1016/j.ceb.2010.05.004", "PMC2910236", "20627678"]}, {"Citation": "Sandhu S.K., Hampson G. The pathogenesis, diagnosis, investigation and management of osteoporosis. J. Clin. Pathol. 2011;64:1042\u20131050. doi: 10.1136/jcp.2010.077842.", "ArticleIdList": ["10.1136/jcp.2010.077842", "21896577"]}, {"Citation": "Tit D.M., Bungau S., Iovan C., Cseppento D.C.N., Endres L., Sava C., Sabau A.M., Furau G., Furau C. Effects of the Hormone Replacement Therapy and of Soy Isoflavones on Bone Resorption in Postmenopause. J. Clin. Med. 2018;7:297. doi: 10.3390/jcm7100297.", "ArticleIdList": ["10.3390/jcm7100297", "PMC6210155", "30248918"]}, {"Citation": "Kruger M.C., Wolber F.M. Osteoporosis: Modern paradigms for last century\u2019s bones. Nutrients. 2016;8:376. doi: 10.3390/nu8060376.", "ArticleIdList": ["10.3390/nu8060376", "PMC4924217", "27322315"]}, {"Citation": "Hu B., Yu B., Tang D., Li S., Wu Y. Daidzein promotes osteoblast proliferation and differentiation in OCT1 cells through stimulating the activation of BMP-2/Smads pathway. Genet. Mol. Res. 2016;15:gmr.15028792. doi: 10.4238/gmr.15028792.", "ArticleIdList": ["10.4238/gmr.15028792", "27420978"]}, {"Citation": "Yamaguchi M., Sugimoto E. Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells: Activation of aminoacyl-tRNA synthetase. Mol. Cell. Biochem. 2000;214:97\u2013102. doi: 10.1023/A:1007199120295.", "ArticleIdList": ["10.1023/A:1007199120295", "11195796"]}, {"Citation": "Kaveeshwar S.A., Cornwall J. The current state of diabetes mellitus in India. Australas. Med. J. 2014;7:45. doi: 10.4066/AMJ.2014.1979.", "ArticleIdList": ["10.4066/AMJ.2014.1979", "PMC3920109", "24567766"]}, {"Citation": "Iorga R.A., Bacalbasa N., Carsote M., Bratu O.G., Stanescu A.M.A., Bungau S., Pantis C., Diaconu C.C. Metabolic and cardiovascular benefits of GLP-1 agonists, besides the hypoglycemic effect (Review) Exp. Ther. Med. 2020;20:2396\u20132400. doi: 10.3892/etm.2020.8714.", "ArticleIdList": ["10.3892/etm.2020.8714", "PMC7401476", "32765722"]}, {"Citation": "Das D., Sarkar S., Bordoloi J., Wann S.B., Kalita J., Manna P. Daidzein, its effects on impaired glucose and lipid metabolism and vascular inflammation associated with type 2 diabetes. Biofactors. 2018;44:407\u2013417. doi: 10.1002/biof.1439.", "ArticleIdList": ["10.1002/biof.1439", "30191623"]}, {"Citation": "Tian D., Liu J., Liu N., Wang R., Ai Y., Jin L., Li F., Wei P., Li Z., Wang C. Daidzin decreases blood glucose and lipid in streptozotocin-induced diabetic mice. Trop. J. Pharm. Res. 2016;15:2435\u20132443. doi: 10.4314/tjpr.v15i11.19.", "ArticleIdList": ["10.4314/tjpr.v15i11.19"]}, {"Citation": "Liang J., Tian Y.-X., Fu L.-M., Wang T.-H., Li H.-J., Wang P., Han R.-M., Zhang J.-P., Skibsted L.H. Daidzein as an antioxidant of lipid: Effects of the microenvironment in relation to chemical structure. J. Agric. Food Chem. 2008;56:10376\u201310383. doi: 10.1021/jf801907m.", "ArticleIdList": ["10.1021/jf801907m", "18841976"]}, {"Citation": "Kampk\u00f6tter A., Chovolou Y., Kulawik A., R\u00f6hrdanz E., Weber N., Proksch P., W\u00e4tjen W. Isoflavone daidzein possesses no antioxidant activities in cell-free assays but induces the antioxidant enzyme catalase. Nutr. Res. 2008;28:620\u2013628. doi: 10.1016/j.nutres.2008.06.002.", "ArticleIdList": ["10.1016/j.nutres.2008.06.002", "19083468"]}, {"Citation": "Toda S., Shirataki Y. Comparison of antioxidative and chelating effects of daidzein and daidzin on protein oxidative modification by copper in vitro. Biol. Trace Elem. Res. 2001;79:83\u201389. doi: 10.1385/BTER:79:1:83.", "ArticleIdList": ["10.1385/BTER:79:1:83", "11318239"]}, {"Citation": "Barton G.M. A calculated response: Control of inflammation by the innate immune system. J. Clin. Investig. 2008;118:413\u2013420. doi: 10.1172/JCI34431.", "ArticleIdList": ["10.1172/JCI34431", "PMC2214713", "18246191"]}, {"Citation": "Yu J., Bi X., Yu B., Chen D. Isoflavones: Anti-inflammatory benefit and possible caveats. Nutrients. 2016;8:361. doi: 10.3390/nu8060361.", "ArticleIdList": ["10.3390/nu8060361", "PMC4924202", "27294954"]}, {"Citation": "Zhang H., Kovacs-Nolan J., Kodera T., Eto Y., Mine Y. \u03b3-Glutamyl cysteine and \u03b3-glutamyl valine inhibit TNF-\u03b1 signaling in intestinal epithelial cells and reduce inflammation in a mouse model of colitis via allosteric activation of the calcium-sensing receptor. Biochim. Biophys. Acta BBA Mol. Basis Dis. 2015;1852:792\u2013804. doi: 10.1016/j.bbadis.2014.12.023.", "ArticleIdList": ["10.1016/j.bbadis.2014.12.023", "25558818"]}, {"Citation": "Birben E., Sahiner U.M., Sackesen C., Erzurum S., Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ. J. 2012;5:9\u201319. doi: 10.1097/WOX.0b013e3182439613.", "ArticleIdList": ["10.1097/WOX.0b013e3182439613", "PMC3488923", "23268465"]}, {"Citation": "Choi E.J., Kim G. The antioxidant activity of daidzein metabolites, O-desmethylangolensin and equol, in HepG2 cells. Mol. Med. Rep. 2014;9:328\u2013332. doi: 10.3892/mmr.2013.1752.", "ArticleIdList": ["10.3892/mmr.2013.1752", "24154619"]}, {"Citation": "Sharma V., Nath D., Gautam S., Radu A.-F., Behl T., Bungau S.G., Vesa C.M. Reviewing the Traditional/Modern Uses, Phytochemistry, Essential Oils/Extracts and Pharmacology of Embelia ribes Burm. Antioxidants. 2022;11:1359. doi: 10.3390/antiox11071359.", "ArticleIdList": ["10.3390/antiox11071359", "PMC9311956", "35883850"]}, {"Citation": "Cheatwood J.L., Emerick A.J., Kartje G.L. Neuronal plasticity and functional recovery after ischemic stroke. Top. Stroke Rehabil. 2008;15:42\u201350. doi: 10.1310/tsr1501-42.", "ArticleIdList": ["10.1310/tsr1501-42", "18250073"]}, {"Citation": "Stout J.M., Knapp A.N., Banz W.J., Wallace D.G., Cheatwood J.L. Subcutaneous daidzein administration enhances recovery of skilled ladder rung walking performance following stroke in rats. Behav. Brain Res. 2013;256:428\u2013431. doi: 10.1016/j.bbr.2013.08.027.", "ArticleIdList": ["10.1016/j.bbr.2013.08.027", "23994543"]}, {"Citation": "Hurtado O., Ballesteros I., Cuartero M.I., Moraga A., Pradillo J.M., Ram\u00edrez-Franco J., Bartolom\u00e9-Mart\u00edn D., Pascual D., Torres M., S\u00e1nchez-Prieto J. Daidzein has neuroprotective effects through ligand-binding-independent PPAR\u03b3 activation. Neurochem. Int. 2012;61:119\u2013127. doi: 10.1016/j.neuint.2012.04.007.", "ArticleIdList": ["10.1016/j.neuint.2012.04.007", "22521773"]}, {"Citation": "Bordet R., Gel\u00e9 P., Duriez P., Fruchart J.C. PPARs: A new target for neuroprotection. J. Neurol. Neurosurg. Psychiatry. 2006;77:285\u2013287. doi: 10.1136/jnnp.2005.077495.", "ArticleIdList": ["10.1136/jnnp.2005.077495", "PMC2077704", "16484630"]}, {"Citation": "Yu C., Tai F., Zeng S., Zhang X. Effects of perinatal daidzein exposure on subsequent behavior and central estrogen receptor \u03b1 expression in the adult male mouse. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2013;43:157\u2013167. doi: 10.1016/j.pnpbp.2012.12.015.", "ArticleIdList": ["10.1016/j.pnpbp.2012.12.015", "23268192"]}, {"Citation": "Atiq A., Shal B., Naveed M., Khan A., Ali J., Zeeshan S., Al-Sharari S.D., Kim Y.S., Khan S. Diadzein ameliorates 5-fluorouracil-induced intestinal mucositis by suppressing oxidative stress and inflammatory mediators in rodents. Eur. J. Pharmacol. 2019;843:292\u2013306. doi: 10.1016/j.ejphar.2018.12.014.", "ArticleIdList": ["10.1016/j.ejphar.2018.12.014", "30529194"]}, {"Citation": "Kim D.H., Jung H.A., Park S.J., Kim J.M., Lee S., Choi J.S., Cheong J.H., Ko K.H., Ryu J.H. The effects of daidzin and its aglycon, daidzein, on the scopolamineinduced memory impairment in male mice. Arch. Pharm. Res. 2010;33:1685\u20131690. doi: 10.1007/s12272-010-1019-2.", "ArticleIdList": ["10.1007/s12272-010-1019-2", "21052945"]}, {"Citation": "Guo Y., Wu G., Su X., Yang H., Zhang J. Antiobesity action of a daidzein derivative on male obese mice induced by a high-fat diet. Nutr. Res. 2009;29:656\u2013663. doi: 10.1016/j.nutres.2009.09.005.", "ArticleIdList": ["10.1016/j.nutres.2009.09.005", "19854381"]}, {"Citation": "Goel R., Chaudhary R. Effect of daidzein on Parkinson disease induced by reserpine in rats. Braz. J. Pharm. Sci. 2020;56:1\u20137. doi: 10.1590/s2175-97902019000318388.", "ArticleIdList": ["10.1590/s2175-97902019000318388"]}, {"Citation": "Woodman O.L., Boujaoude M. Chronic treatment of male rats with daidzein and 17\u03b2-oestradiol induces the contribution of EDHF to endothelium-dependent relaxation. Br. J. Pharmacol. 2004;141:322\u2013328. doi: 10.1038/sj.bjp.0705603.", "ArticleIdList": ["10.1038/sj.bjp.0705603", "PMC1574190", "14691049"]}, {"Citation": "Ko Y.-H., Kim S.Y., Lee S.-Y., Jang C.-G. 6,7,4\u2032-Trihydroxyisoflavone, a major metabolite of daidzein, improves learning and memory via the cholinergic system and the p-CREB/BDNF signaling pathway in mice. Eur. J. Pharmacol. 2018;826:140\u2013147. doi: 10.1016/j.ejphar.2018.02.048.", "ArticleIdList": ["10.1016/j.ejphar.2018.02.048", "29510125"]}, {"Citation": "Park M.-H., Ju J.-W. Daidzein inhibits carbohydrate digestive enzymes in vitro and alleviates postprandial hyperglycemia in diabetic mice. Eur. J. Pharmacol. 2013;712:48\u201352. doi: 10.1016/j.ejphar.2013.04.047.", "ArticleIdList": ["10.1016/j.ejphar.2013.04.047", "23669248"]}, {"Citation": "Cao Y., Yang X., Liu J., Li K. Effects of daidzein sulfates on blood pressure and artery of rats. Basic Clin. Pharmacol. Toxicol. 2006;99:425\u2013430. doi: 10.1111/j.1742-7843.2006.pto_565.x.", "ArticleIdList": ["10.1111/j.1742-7843.2006.pto_565.x", "17169123"]}, {"Citation": "Sharma S., Singh M., Sharma P.L. Ameliorative effect of daidzein: A caveolin-1 inhibitor in vascular endothelium dysfunction induced by ovariectomy. Indian J. Exp. Biol. 2012;50:28\u201334.", "ArticleIdList": ["22279937"]}, {"Citation": "Choi E.J. The prooxidant, rather than antioxidant, acts of daidzein in vivo and in vitro: Daidzein suppresses glutathione metabolism. Eur. J. Pharmacol. 2006;542:162\u2013169. doi: 10.1016/j.ejphar.2006.05.020.", "ArticleIdList": ["10.1016/j.ejphar.2006.05.020", "16797001"]}, {"Citation": "Zeng S., Tai F., Zhai P., Yuan A., Jia R., Zhang X. Effect of daidzein on anxiety, social behavior and spatial learning in male Balb/cJ mice. Pharmacol. Biochem. Behav. 2010;96:16\u201323. doi: 10.1016/j.pbb.2010.03.015.", "ArticleIdList": ["10.1016/j.pbb.2010.03.015", "20381516"]}, {"Citation": "Farhana A., Veeresh B., Rao R. Protective Role of Diadzein in L-Arginine-Induced Acute pancreatitis in Rats. YMER Digit. 2022;21:451\u2013460. doi: 10.37896/YMER21.06/44.", "ArticleIdList": ["10.37896/YMER21.06/44"]}, {"Citation": "Sakamoto Y., Naka A., Ohara N., Kondo K., Iida K. Daidzein regulates proinflammatory adipokines thereby improving obesity-related inflammation through PPAR\u03b3. Mol. Nutr. Food Res. 2014;58:718\u2013726. doi: 10.1002/mnfr.201300482.", "ArticleIdList": ["10.1002/mnfr.201300482", "24343975"]}, {"Citation": "Huang G., Xu J., Guo T.L. Isoflavone daidzein regulates immune responses in the B6C3F1 and non-obese diabetic (NOD) mice. Int. Immunopharmacol. 2019;71:277\u2013284. doi: 10.1016/j.intimp.2019.03.046.", "ArticleIdList": ["10.1016/j.intimp.2019.03.046", "PMC6529284", "30927738"]}, {"Citation": "Al\u00f2 R., Fazzari G., Zizza M., Avolio E., Di Vito A., Bruno R., Cuda G., Barni T., Canonaco M., Facciolo R.M. Daidzein Pro-cognitive Effects Coincided with Changes of Brain Neurotensin1 Receptor and Interleukin-10 Expression Levels in Obese Hamsters. Neurotox. Res. 2021;39:645\u2013657. doi: 10.1007/s12640-020-00328-4.", "ArticleIdList": ["10.1007/s12640-020-00328-4", "33428179"]}, {"Citation": "Crespillo A., Alonso M., Vida M., Pav\u00f3n F.J., Serrano A., Rivera P., Romero-Zerbo Y., Fern\u00e1ndez-Llebrez P., Mart\u00ednez A., P\u00e9rez-Valero V. Reduction of body weight, liver steatosis and expression of stearoyl-CoA desaturase 1 by the isoflavone daidzein in diet-induced obesity. Br. J. Pharmacol. 2011;164:1899\u20131915. doi: 10.1111/j.1476-5381.2011.01477.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01477.x", "PMC3246714", "21557739"]}, {"Citation": "Kim M.H., Park J.S., Jung J.W., Byun K.W., Kang K.S., Lee Y.S. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism. Int. J. Obes. 2011;35:1019\u20131030. doi: 10.1038/ijo.2010.256.", "ArticleIdList": ["10.1038/ijo.2010.256", "21157426"]}, {"Citation": "Mohamad-Shahi M., Karandish M., Haidari F., Omidian K., Fatemi-Tabatabayei S.-R., Rafiei H. Effect of daidzein-low-calorie diet on body weight, serum levels of glucose, resistin, and high sensitive C-reactive protein in high fat, high calorie diet induced rats. Saudi. Med. J. 2012;33:70\u201375.", "ArticleIdList": ["22273652"]}, {"Citation": "Park S.A., Choi M.-S., Cho S.-Y., Seo J.-S., Jung U.J., Kim M.-J., Sung M.-K., Park Y.B., Lee M.-K. Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci. 2006;79:1207\u20131213. doi: 10.1016/j.lfs.2006.03.022.", "ArticleIdList": ["10.1016/j.lfs.2006.03.022", "16647724"]}, {"Citation": "Tomar A., Kaushik S., Khan S.I., Bisht K., Nag T.C., Arya D.S., Bhatia J. The dietary isoflavone daidzein mitigates oxidative stress, apoptosis, and inflammation in CDDP-induced kidney injury in rats: Impact of the MAPK signaling pathway. J. Biochem. Mol. Toxicol. 2020;34:e22431. doi: 10.1002/jbt.22431.", "ArticleIdList": ["10.1002/jbt.22431", "31833131"]}, {"Citation": "Alshamrani M. Broad-Spectrum Theranostics and Biomedical Application of Functionalized Nanomaterials. Polymers. 2022;14:1221. doi: 10.3390/polym14061221.", "ArticleIdList": ["10.3390/polym14061221", "PMC8956086", "35335551"]}, {"Citation": "Riehemann K., Schneider S.W., Luger T.A., Godin B., Ferrari M., Fuchs H. Nanomedicine\u2014Challenge and perspectives. Angew. Chem. Int. Ed. 2009;48:872\u2013897. doi: 10.1002/anie.200802585.", "ArticleIdList": ["10.1002/anie.200802585", "PMC4175737", "19142939"]}, {"Citation": "Boulaiz H., Alvarez P.J., Ramirez A., Marchal J.A., Prados J., Rodr\u00edguez-Serrano F., Per\u00e1n M., Melguizo C., Aranega A. Nanomedicine: Application areas and development prospects. Int. J. Mol. Sci. 2011;12:3303\u20133321. doi: 10.3390/ijms12053303.", "ArticleIdList": ["10.3390/ijms12053303", "PMC3116192", "21686186"]}, {"Citation": "Pison U., Welte T., Giersig M., Groneberg D.A. Nanomedicine for respiratory diseases. Eur. J. Pharmacol. 2006;533:341\u2013350. doi: 10.1016/j.ejphar.2005.12.068.", "ArticleIdList": ["10.1016/j.ejphar.2005.12.068", "16434033"]}, {"Citation": "Zou T., Gu L. TPGS emulsified zein nanoparticles enhanced oral bioavailability of daidzin: In vitro characteristics and in vivo performance. Mol. Pharm. 2013;10:2062\u20132070. doi: 10.1021/mp400086n.", "ArticleIdList": ["10.1021/mp400086n", "23557122"]}, {"Citation": "Ozakar R.S., Cetin M., Taghizadehghalehjoughi A., Hacimuftuoglu A. Preparation and In Vitro Evaluation of Daidzein-Loaded Nanoparticulate Systems. Eurasia Proc. Health Environ. Life Sci. 2021;1:1\u201312."}, {"Citation": "Gao Y., Gu W., Chen L., Xu Z., Li Y. The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases. Biomaterials. 2008;29:4129\u20134136. doi: 10.1016/j.biomaterials.2008.07.008.", "ArticleIdList": ["10.1016/j.biomaterials.2008.07.008", "18667234"]}, {"Citation": "Song J., Fan X., Shen Q. Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery. Int. J. Pharm. 2016;501:245\u2013252. doi: 10.1016/j.ijpharm.2016.02.003.", "ArticleIdList": ["10.1016/j.ijpharm.2016.02.003", "26851353"]}, {"Citation": "Wusiman Z., Sun L., Zuo T., Yin Y., Yang X., Shen Q. Core\u2013shell-type polymer\u2013lipid nanoparticles for the transdermal delivery of daidzein. Micro Nano Lett. 2018;13:1363\u20131366. doi: 10.1049/mnl.2018.5095.", "ArticleIdList": ["10.1049/mnl.2018.5095"]}, {"Citation": "Zhang Z., Huang Y., Gao F., Gao Z., Bu H., Gu W., Li Y. A self-assembled nanodelivery system enhances the oral bioavailability of daidzein: In vitro characteristics and in vivo performance. Nanomedicine. 2011;6:1365\u20131379. doi: 10.2217/nnm.11.39.", "ArticleIdList": ["10.2217/nnm.11.39", "22026378"]}, {"Citation": "Wang H., Xiao Y., Wang H., Sang Z., Han X., Ren S., Du R., Shi X., Xie Y. Development of daidzein nanosuspensions: Preparation, characterization, in vitro evaluation, and pharmacokinetic analysis. Int. J. Pharm. 2019;566:67\u201376. doi: 10.1016/j.ijpharm.2019.05.051.", "ArticleIdList": ["10.1016/j.ijpharm.2019.05.051", "31125715"]}, {"Citation": "Lv L., Fu C., Zhang F., Wang S. Thermally-induced whey protein isolate-daidzein co-assemblies: Protein-based nanocomplexes as an inhibitor of precipitation/crystallization for hydrophobic drug. Food Chem. 2019;275:273\u2013281. doi: 10.1016/j.foodchem.2018.09.057.", "ArticleIdList": ["10.1016/j.foodchem.2018.09.057", "30724197"]}, {"Citation": "Kaplan A.B.U., Cetin M., Orgul D., Taghizadehghalehjoughi A., Hac\u0131muftuoglu A., Hekimoglu S. Formulation and in vitro evaluation of topical nanoemulsion and nanoemulsion-based gels containing daidzein. J. Drug Deliv. Sci. Technol. 2019;52:189\u2013203. doi: 10.1016/j.jddst.2019.04.027.", "ArticleIdList": ["10.1016/j.jddst.2019.04.027"]}, {"Citation": "Wang Q., Liu W., Wang J., Liu H., Chen Y. Preparation and pharmacokinetic study of Daidzein Long-circulating liposomes. Nanoscale Res. Lett. 2019;14:321. doi: 10.1186/s11671-019-3164-y.", "ArticleIdList": ["10.1186/s11671-019-3164-y", "PMC6794334", "31617108"]}, {"Citation": "Shen Q., Li X., Yuan D., Jia W. Enhanced oral bioavailability of daidzein by self-microemulsifying drug delivery system. Chem. Pharm. Bull. 2010;58:639\u2013643. doi: 10.1248/cpb.58.639.", "ArticleIdList": ["10.1248/cpb.58.639", "20460789"]}, {"Citation": "DeFrates K., Markiewicz T., Gallo P., Rack A., Weyhmiller A., Jarmusik B., Hu X. Protein polymer-based nanoparticles: Fabrication and medical applications. Int. J. Mol. Sci. 2018;19:1717. doi: 10.3390/ijms19061717.", "ArticleIdList": ["10.3390/ijms19061717", "PMC6032199", "29890756"]}, {"Citation": "Zieli\u0144ska A., Carreir\u00f3 F., Oliveira A.M., Neves A., Pires B., Venkatesh D.N., Durazzo A., Lucarini M., Eder P., Silva A.M. Polymeric nanoparticles: Production, characterization, toxicology and ecotoxicology. Molecules. 2020;25:3731. doi: 10.3390/molecules25163731.", "ArticleIdList": ["10.3390/molecules25163731", "PMC7464532", "32824172"]}, {"Citation": "Chan J.M., Valencia P.M., Zhang L., Langer R., Farokhzad O.C. Cancer Nanotechnology. Springer; Berlin/Heidelberg, Germany: 2010. Polymeric nanoparticles for drug delivery; pp. 163\u2013175.", "ArticleIdList": ["20217595"]}, {"Citation": "Rao J.P., Geckeler K.E. Polymer nanoparticles: Preparation techniques and size-control parameters. Prog. Polym. Sci. 2011;36:887\u2013913. doi: 10.1016/j.progpolymsci.2011.01.001.", "ArticleIdList": ["10.1016/j.progpolymsci.2011.01.001"]}, {"Citation": "Vauthier C., Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm. Res. 2009;26:1025\u20131058. doi: 10.1007/s11095-008-9800-3.", "ArticleIdList": ["10.1007/s11095-008-9800-3", "19107579"]}, {"Citation": "Nagavarma B.V.N., Yadav H.K.S., Ayaz A., Vasudha L.S., Shivakumar H.G. Different techniques for preparation of polymeric nanoparticles-a review. Asian J. Pharm. Clin. Res. 2012;5:16\u201323."}, {"Citation": "Lingayat V.J., Zarekar N.S., Shendge R.S. Solid lipid nanoparticles: A review. Nanosci. Nanotechnol. Res. 2017;4:67\u201372."}, {"Citation": "Yadav N., Khatak S., Sara U.V.S. Solid lipid nanoparticles-a review. Int. J. Appl. Pharm. 2013;5:8\u201318."}, {"Citation": "\u00dcner M., Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int. J. Nanomed. 2007;2:289.", "ArticleIdList": ["PMC2676658", "18019829"]}, {"Citation": "Pizzol C.D., Filippin-Monteiro F.B., Restrepo J.A.S., Pittella F., Silva A.H., de Souza P.A., de Campos A.M., Creczynski-Pasa T.B. Influence of surfactant and lipid type on the physicochemical properties and biocompatibility of solid lipid nanoparticles. Int. J. Environ. Res. Public Health. 2014;11:8581\u20138596. doi: 10.3390/ijerph110808581.", "ArticleIdList": ["10.3390/ijerph110808581", "PMC4143879", "25141003"]}, {"Citation": "Duong V.-A., Nguyen T.-T.-L., Maeng H.-J. Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method. Molecules. 2020;25:4781. doi: 10.3390/molecules25204781.", "ArticleIdList": ["10.3390/molecules25204781", "PMC7587569", "33081021"]}, {"Citation": "Haider M., Abdin S.M., Kamal L., Orive G. Nanostructured lipid carriers for delivery of chemotherapeutics: A review. Pharmaceutics. 2020;12:288. doi: 10.3390/pharmaceutics12030288.", "ArticleIdList": ["10.3390/pharmaceutics12030288", "PMC7151211", "32210127"]}, {"Citation": "Mukherjee S., Ray S., Thakur R.S. Solid lipid nanoparticles: A modern formulation approach in drug delivery system. Indian J. Pharm. Sci. 2009;71:349. doi: 10.4103/0250-474X.57282.", "ArticleIdList": ["10.4103/0250-474X.57282", "PMC2865805", "20502539"]}, {"Citation": "Patel D.K., Tripathy S., Nair S.K., Kesharwani R. Nanostructured lipid carrier (Nlc) a modern approach for topical delivery: A review. World J. Pharm. Pharm. Sci. 2013;2:921\u2013938."}, {"Citation": "Li Q., Cai T., Huang Y., Xia X., Cole S.P.C., Cai Y. A review of the structure, preparation, and application of NLCs, PNPs, and PLNs. Nanomaterials. 2017;7:122. doi: 10.3390/nano7060122.", "ArticleIdList": ["10.3390/nano7060122", "PMC5485769", "28554993"]}, {"Citation": "Gomaa E., Fathi H.A., Eissa N.G., Elsabahy M. Methods for preparation of nanostructured lipid carriers. Methods. 2022;199:3\u20138. doi: 10.1016/j.ymeth.2021.05.003.", "ArticleIdList": ["10.1016/j.ymeth.2021.05.003", "33992771"]}, {"Citation": "Movassaghian S., Merkel O.M., Torchilin V.P. Applications of polymer micelles for imaging and drug delivery. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2015;7:691\u2013707. doi: 10.1002/wnan.1332.", "ArticleIdList": ["10.1002/wnan.1332", "25683687"]}, {"Citation": "Nishiyama N., Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol. Ther. 2006;112:630\u2013648. doi: 10.1016/j.pharmthera.2006.05.006.", "ArticleIdList": ["10.1016/j.pharmthera.2006.05.006", "16815554"]}, {"Citation": "Patel V.R., Agrawal Y.K. Nanosuspension: An approach to enhance solubility of drugs. J. Adv. Pharm. Technol. Res. 2011;2:81.", "ArticleIdList": ["PMC3217698", "22171298"]}, {"Citation": "Krishna K.B., Prabhakar C. A review on nanosuspensions in drug delivery. Int. J. Pharma. Bio Sci. 2011;2:549\u2013558."}, {"Citation": "Lakshmi P., Kumar G.A. Nanosuspension technology: A review. Int. J. Pharm. Pharm. Sci. 2010;2:35\u201340."}, {"Citation": "Patravale V.B., Date A.A., Kulkarni R.M. Nanosuspensions: A promising drug delivery strategy. J. Pharm. Pharmacol. 2004;56:827\u2013840. doi: 10.1211/0022357023691.", "ArticleIdList": ["10.1211/0022357023691", "15233860"]}, {"Citation": "Patel M., Shah A., Patel N.M., Patel M.R., Patel K.R. Nanosuspension: A novel approach for drug delivery system. Jpsbr. 2011;1:1\u201310."}, {"Citation": "Patel R.P., Joshi J.R. An overview on nanoemulsion: A novel approach. Int. J. Pharm. Sci. Res. 2012;3:4640."}, {"Citation": "Nikam T.H., Patil M.P., Patil S.S., Vadnere G.P., Lodhi S. Nanoemulsion: A brief review on development and application in Parenteral Drug Delivery. Adv. Pharm. J. 2018;3:43\u201354. doi: 10.31024/apj.2018.3.2.2.", "ArticleIdList": ["10.31024/apj.2018.3.2.2"]}, {"Citation": "Jaiswal M., Dudhe R., Sharma P.K. Nanoemulsion: An advanced mode of drug delivery system. 3 Biotech. 2015;5:123\u2013127. doi: 10.1007/s13205-014-0214-0.", "ArticleIdList": ["10.1007/s13205-014-0214-0", "PMC4362737", "28324579"]}, {"Citation": "Sharma N., Bansal M., Visht S., Sharma P.K., Kulkarni G.T. Nanoemulsion: A new concept of delivery system. Chron. Young Sci. 2010;1:2\u20136."}, {"Citation": "Bozzuto G., Molinari A. Liposomes as nanomedical devices. Int. J. Nanomed. 2015;10:975. doi: 10.2147/IJN.S68861.", "ArticleIdList": ["10.2147/IJN.S68861", "PMC4324542", "25678787"]}, {"Citation": "Maherani B., Arab-Tehrany E., Mozafari M.R., Gaiani C., Linder M. Liposomes: A review of manufacturing techniques and targeting strategies. Curr. Nanosci. 2011;7:436\u2013452. doi: 10.2174/157341311795542453.", "ArticleIdList": ["10.2174/157341311795542453"]}, {"Citation": "Salimi A. Liposomes as a novel drug delivery system: Fundamental and pharmaceutical application. Asian J. Pharm. 2018;12:S31\u2013S41."}, {"Citation": "Gbian D.L., Omri A. Current and novel therapeutic strategies for the management of cystic fibrosis. Expert Opin. Drug Deliv. 2021;18:535\u2013552. doi: 10.1080/17425247.2021.1874343.", "ArticleIdList": ["10.1080/17425247.2021.1874343", "33426936"]}, {"Citation": "Akbarzadeh A., Rezaei-Sadabady R., Davaran S., Joo S.W., Zarghami N., Hanifehpour Y., Samiei M., Kouhi M., Nejati-Koshki K. Liposome: Classification, preparation, and applications. Nanoscale Res. Lett. 2013;8:102. doi: 10.1186/1556-276X-8-102.", "ArticleIdList": ["10.1186/1556-276X-8-102", "PMC3599573", "23432972"]}, {"Citation": "Kyatanwar A.U., Jadhav K.R., Kadam V.J. Self micro-emulsifying drug delivery system (SMEDDS) J. Pharm. Res. 2010;3:75\u201383."}, {"Citation": "Patel D., Sawant K.K. Self micro-emulsifying drug delivery system: Formulation development and biopharmaceutical evaluation of lipophilic drugs. Curr. Drug Deliv. 2009;6:419\u2013424. doi: 10.2174/156720109789000519.", "ArticleIdList": ["10.2174/156720109789000519", "19534704"]}, {"Citation": "Gurram A.K., Deshpande P.B., Kar S.S., Nayak U.Y., Udupa N., Reddy M.S. Role of components in the formation of self-microemulsifying drug delivery systems. Indian J. Pharm. Sci. 2015;77:249.", "ArticleIdList": ["PMC4502138", "26180269"]}, {"Citation": "Clinical Trials Assessing the Medical Role of Daidzein. U.S. National Library of Medicine.  [(accessed on 12 December 2022)]; Available online:  https://clinicaltrials.gov/"}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "1", "Day": "3"}, {"Year": "2023", "Month": "2", "Day": "2"}, {"Year": "2023", "Month": "2", "Day": "10"}, {"Year": "2023", "Month": "2", "Day": "25", "Hour": "3", "Minute": "57"}, {"Year": "2023", "Month": "2", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "13"}], "PublicationStatus": "epublish", "ArticleIdList": ["36838751", "PMC9958968", "10.3390/molecules28041765", "molecules28041765"]}}], "PubmedBookArticle": []}